Literature DB >> 12153837

Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans.

Steven M Southwick1, Michael Davis, Beverly Horner, Larry Cahill, Charles A Morgan, Paul E Gold, J Douglas Bremner, Dennis C Charney.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the effect of enhanced noradrenergic activity on memory consolidation in humans.
METHOD: Thirty healthy subjects (21 men and nine women) viewed a series of 12 slides that depicted an emotionally arousing story. Five minutes after viewing the slides, subjects received either intravenous yohimbine or intravenous placebo in a double-blind randomized fashion. Multiple blood samples were drawn for determining plasma free 3-methoxy-4-hydroxyphenylglycol (MHPG). One week later subjects took a surprise memory test for the slides.
RESULTS: There was no significant difference in memory score between yohimbine and placebo groups. Linear regression revealed a significant effect of MHPG on memory score for the group as a whole (subjects who had received yohimbine and those who had received placebo) and for the placebo group alone.
CONCLUSIONS: These findings strengthen support for the hypothesis that enhanced memory for emotionally arousing events in humans depends critically on postlearning adrenergic modulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153837     DOI: 10.1176/appi.ajp.159.8.1420

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  40 in total

1.  Enhanced human memory consolidation with post-learning stress: interaction with the degree of arousal at encoding.

Authors:  Larry Cahill; Lukasz Gorski; Kathryn Le
Journal:  Learn Mem       Date:  2003 Jul-Aug       Impact factor: 2.460

2.  Emotion enhances remembrance of neutral events past.

Authors:  Adam K Anderson; Peter E Wais; John D E Gabrieli
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-24       Impact factor: 11.205

3.  Emotional memories are not all created equal: evidence for selective memory enhancement.

Authors:  Adam K Anderson; Yuki Yamaguchi; Wojtek Grabski; Dominika Lacka
Journal:  Learn Mem       Date:  2006-11-13       Impact factor: 2.460

Review 4.  PTSD and gene variants: new pathways and new thinking.

Authors:  Kelly Skelton; Kerry J Ressler; Seth D Norrholm; Tanja Jovanovic; Bekh Bradley-Davino
Journal:  Neuropharmacology       Date:  2011-02-26       Impact factor: 5.250

5.  Deepened extinction following compound stimulus presentation: noradrenergic modulation.

Authors:  Patricia H Janak; Laura H Corbit
Journal:  Learn Mem       Date:  2010-12-14       Impact factor: 2.460

6.  Unannounced memory tests are not necessarily unexpected by participants: test expectation and its consequences in the repeated test paradigm.

Authors:  Aileen Oeberst; Isabel Lindner
Journal:  Cogn Process       Date:  2015-06-19

Review 7.  Psychobiology of PTSD in the acute aftermath of trauma: Integrating research on coping, HPA function and sympathetic nervous system activity.

Authors:  Matthew C Morris; Uma Rao
Journal:  Asian J Psychiatr       Date:  2012-09-06

Review 8.  Electrical stimulation of cranial nerves in cognition and disease.

Authors:  Devin Adair; Dennis Truong; Zeinab Esmaeilpour; Nigel Gebodh; Helen Borges; Libby Ho; J Douglas Bremner; Bashar W Badran; Vitaly Napadow; Vincent P Clark; Marom Bikson
Journal:  Brain Stimul       Date:  2020-02-23       Impact factor: 8.955

9.  Melatonin improves memory acquisition under stress independent of stress hormone release.

Authors:  Ulrike Rimmele; Maria Spillmann; Carmen Bärtschi; Oliver T Wolf; Cora S Weber; Ulrike Ehlert; Petra H Wirtz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

10.  Impaired cognition and attention in adults: pharmacological management strategies.

Authors:  Hervé Allain; Yvette Akwa; Lucette Lacomblez; Alain Lieury; Danièle Bentué-Ferrer
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.